Cell proliferation and p53 protein expression in cutaneous epithelial neoplasms

American Journal of Dermatopathology

Volumn 18, Issue 6, 1996, Pages 580-588

  Onodera, Hanae ^a   Nakamura, Shin Ichi ^a   Sugai, Tamotsu ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Basal cell carcinoma; Bowen's disease; Cell proliferation; p53 protein; Solar keratosis; Squamous cell carcinoma

Indexed keywords

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CELL; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; COLORING AGENTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS; KERATOSIS, SEBORRHEIC; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; NUCLEOLUS ORGANIZER REGION; SILVER; SKIN NEOPLASMS; SUNLIGHT; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030473904     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199612000-00005     Document Type: Article

References (40)

1. Okabe Y, Nakamura S, Okamura H, Matano S, Kohayashi K, Ohtake S, Yoshida T, Matsuda T, Mizukami Y, Nonomura A. The relation of argyrophilic proteins of nucleolar organizer regions (AgNORs) to the proportions of Ki-67 or DNA polyermase α-reacting cells in non-Hodgkin's lymphomas. Anticancer Res 1991;11:2031-6.
2. Weidner N, Moore DH, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol 1994;25:337-42.
3. Soomro IN, Whimster WF. Growth fraction in lung tumors determined by Ki67 immunostaining and comparison with AgNOR scores. J Pathol 1990;162:217-22.
4. Kakeji Y, Korenaga D, Tsujitani S, Haraguchi M, Maehara Y, Sugimachi K. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis gastric cancer. Cancer Res 1991;51:3503-6.
5. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T. Proliferative potential of brain tumors. Cancer 1993;71:199-206.
6. Sasaki K. Measurement of tritiated thymidine labeling index by incubation in vitro of surgically removed cervical cancer. Jpn J Cancer Res 1977;68:307-13.
7. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Im J Cancer 1983;31:13-20.
8. Lee MYWT, Alejandro R, Toomey NL. Immunohistochemical studies of DNA polymerase δ: Relationships with DNA polymerase α. Arch Biochem Biophys 1989;272:1-9.
9. Mathews MB, Bernstein RM, Franza BR, Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984;309:374-6.
10. Toschi L, Bravo R. Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol 1988;107:1623-8.
11. Bravo R, Macdonald-B H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 1987;105:1549-54.
12. Hall PA, Coates PJ, Goodlad RA, Hart IR, Lane DP. Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo. Br J Cancer 1994;70:244-7.
13. Underwood JCE. Nucleolar organizer regions. In: Hall PA, Levinson DA, Wright NA, eds. Assessment of cell proliferation in clinical practice. London: Springer-Verlag, 1991:161-75.
14. Ploton D, Bobichon H, Adnet JJ. Ultrastructural localization of nor in nucleoli of human breast cancer tissues using a one-step Ag-NOR staining method. Biol Cell 1982;43:229-32.
15. Lipponen PK, Eskelinen MJ, Nordling S. Nucleolar organizer regions (AgNORs) as predictors in transitional cell bladder cancer. Br J Cancer 1991;64:1139-44.
16. Morita M, Kuwano H, Matsuda H, Moriguchi S, Sugimachi K. Prognostic significance of argyrophilic nucleolar organizer regions in esophageal carcinoma. Cancer Res 1991;51:5339-41.
17. Cattoretti G, Backer MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
18. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumor antigen to band 17p13. Nature 1986;320:84-5.
19. Lane DP, Crawford LV. T-antigen is bound to a host protein in SV 40-transformed cells. Nature 1979;278:261-3.
20. Marks R, Rennie G. Malignant transformation of solar keratosis to squamous cell carcinoma. Lancet 1988;1:795-7.
21. Lever WF, Schaumburg-Lever G. Histopathology of the skin. Philadelphia: J.B. Lippincott Company, 1990.
22. Vojtěšek B, Bártek J, Midgley CA, Lane DP. An immunohistochemical analysis of the human nuclear phosphoprotein p53: New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Meth 1992;151:237-44.
23. Fallowfield ME, Cook MG. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions. Histopathology 1989;14:299-304.
24. Howat AJ, Wright AL, Cotton DWK, Reeve S, Bleehen SS. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions. Am J Dermatopathol 1990;12:156-61.
25. Gregorio C, Losi L, Annessi G, Botticelli A. Nucleolar organizer regions in malignant melanoma and melanocytic nevi: Comparison of two counting methods. Am J Dermatopathol 1991;13:329-33.
26. Smolle J, Soyer H-P, Kerl H. Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody. Am J Dermatopathol 1989;11:301-7.
27. Jozsa L, Kannus P, Jarvinen M, Isola J, Kvist M, Lehto M. Atrophy and regeneration of rat calf muscles cause reversible changes in the number of nucleolar organizer regions. Lab Invest 1993;69:231-7.
28. Reich NC, Oren M, Levine AJ. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol 1983;3:2143-50.
29. Jenkins JR, Rudge K, Chumakov P, Currie GA. The cellular oncogene p53 can be activated by mutagenesis. Nature 1985;317:816-8.
30. McGregor JM, Yu CC-W, Dublin EA, Levinson DA, MacDonald DM. Aberrant expression of p53 tumor-suppressor protein in non-melanoma skin cancer. Br J Dermatol 1992;127:463-9.
31. Ro YS, Cooper PN, Lee JA, Quinn AG, Harrison D, Lane D, Horne CHW, Rees JL, Angus B. p53 protein expression in benign and malignant skin tumours. Br J Dermatol 1993;128:237-41.
32. Sim CS, Slater SD, McKee PH. Mutant p53 protein is expressed in Bowen's disease. Am J Dermatopathol 1992;14:195-9.
33. Sim CS, Slater S, McKee PH. Mutant p53 expression in solar keratosis: an immunohistochemical study. J Cutan Pathol 1992;19:302-8.
34. Lee Y-S, Teh M. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of the skin. Cancer 1994;73:2317-23.
35. Maltzman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 1984;4:1689-94.
36. Hall PA, McKee PH, Menage HP, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993;8:203-7.
37. Lane DP. p53, guardian of the genome. Nature 1992;358:15-6.
38. Shea CR, McNutt NS, Volkenandt M, Lugo J, Prioleau PG, Albino AP. Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol 1992;141:25-9.
39. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992;69:1237-45.
40. Marchetti A, Buttitta F, Pellegrini S, Merlo G, Chella A, Angeletti CA. Bevilacqua G. mdm-2 gene amplification and Overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations. Diagn Mol Pathol 1995;4:93-7.